Evidence map›Paper›PMID 33142910›Full record

ArticleInternational journal of molecular sciences2020

Histamine H

Rei Kawashima, Shun Tamaki, Fumitaka Kawakami, Tatsunori Maekawa, Takafumi Ichikawa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Use of Antihistamine Drugs in Colitis: A Review.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rei KawashimaDepartment of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Kanagawa 252-0374, Japan.
Shun TamakiDepartment of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Kanagawa 252-0374, Japan.
Fumitaka KawakamiDepartment of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Kanagawa 252-0374, Japan.
Tatsunori MaekawaDepartment of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Kanagawa 252-0374, Japan.ORCID 0000-0002-1214-9959
Takafumi IchikawaDepartment of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Kanagawa 252-0374, Japan.
Kitasato University · JP

Funding

Japan Society for the Promotion of Science 19K08379Japan Society for the Promotion of Science 20K08294Kitasato University School of Allied Health Sciences 2020-1004Kitasato University School of Allied Health Sciences 2020-1009
6 · The paper itself

Abstract

Dysbiosis, an imbalance of intestinal flora, can cause serious conditions such as obesity, cancer, and psychoneurological disorders. One cause of dysbiosis is inflammation. Ulcerative enteritis is a side effect of non-steroidal anti-inflammatory drugs (NSAIDs). To counteract this side effect, we proposed the concurrent use of histamine H

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalAnti-Ulcer AgentsDysbiosisFecesHistamine H2 AntagonistsIndomethacinInflammationIntestinal MucosaMaleMiceMice, Inbred BALB CPharmaceutical PreparationsTreatment OutcomeAnti-Inflammatory Agents, Non-SteroidalAnti-Ulcer AgentsHistamine H2 AntagonistsIndomethacinPharmaceutical PreparationsdysbiosisfecesH2RA (histamine H2 receptor antagonist)intestinal floraNSAIDs (non-steroidal anti-inflammatory drugs)organic acid

Identifiers

PMID33142910
PMCPMC7662336
OpenAlexW3096525951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.